Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.
第一作者:
Sam,Schulman
第一单位:
McMaster University, Thrombosis and Atherosclerosis Research Institute, and Ontario Clinical Oncology Group, Hamilton, Ontario, Canada. schulms@mcmaster.ca
作者:
医学主题词
抗凝药(Anticoagulants);双盲法(Double-Blind Method);药物监测(Drug Monitoring);出血(Hemorrhage);人类(Humans);国际标准化比(International Normalized Ratio);血栓栓塞(Thromboembolism);时间因素(Time Factors);华法林(Warfarin)
DOI
10.7326/0003-4819-155-10-201111150-00003
PMID
22084331
发布时间
2025-04-28
- 浏览8
Annals of internal medicine
653-9, W201-3页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



